Indian authorities have seized counterfeit Abhayrab vaccine vials in Delhi, echoing a warning issued by Australian health officials months earlier. The discovery highlights critical vulnerabilities in the vaccine supply chain for a potentially fatal disease.
- Counterfeit Abhayrab vials seized from an unlicensed premise in Mukherjee Nagar, Delhi.
- Australia's ATAGI issued a precautionary warning in December 2025 regarding fake batches in India.
- Central Drugs Laboratory (CDL) Kasauli confirmed the seized samples are 'Not of Standard Quality'.
- India reports the highest global burden of rabies deaths, exceeding 5,700 annually.
A major security breach in the pharmaceutical supply chain has come to light as Indian drug regulators flag suspected counterfeit vials of Abhayrab, a widely used anti-rabies vaccine. The vials were seized from an unlicensed residential premise in Delhi, marking a troubling return of counterfeit vaccines in a country where rabies remains a critical public health threat.
The current crisis is particularly alarming because it follows a global red flag. In December 2025, the Australian Technical Advisory Group on Immunisation (ATAGI) issued a warning to travelers and healthcare providers. They identified a specific counterfeit batch (KA24014) of Abhayrab circulating in India, noting discrepancies in formulation, packaging, and labeling. Australian authorities went as far as advising travelers who received the vaccine in India to seek replacement doses if they could not verify their batch numbers.
Why This Matters
BozokMedia analysis shows that the distribution of fake rabies vaccines is not just a regulatory failure but a life-threatening risk. Unlike routine immunizations, rabies shots are administered as post-exposure prophylaxis (PEP). If a patient receives a fake dose, they are left entirely unprotected against a virus that is almost invariably fatal once symptoms emerge. With India recording 9 million animal bites annually, the stakes for vaccine integrity are astronomical.
"Unlike many routine vaccines, rabies shots are often administered after exposure, leaving zero room for uncertainty regarding the product's reliability."
The manufacturer, Indian Immunological Ltd (IIL)—a subsidiary of the National Dairy Development Board—has distanced itself from the seized products. IIL reported that the government laboratory identified 17 distinct differences between the counterfeit vials and genuine retention samples, including errors in QR-code verification, cap color, and license details.
Historically, India has struggled with the highest burden of rabies globally. The emergence of fake batches, first flagged by an international body and then confirmed by local seizures, points to a sophisticated network of counterfeiters exploiting the urgent demand for life-saving treatment.
| Feature | Genuine Abhayrab Vaccine | Counterfeit/Seized Vaccine |
|---|---|---|
| Quality Standard | CDL Certified | Not of Standard Quality (NSQ) |
| Packaging | Verified QR Codes & Seals | Variations in Print & Cap Color |
| Potency | Triggers Immune Response | Failed Potency Requirements |
Frequently Asked Questions
Q1: Are all Abhayrab vaccines in the market fake?
No. Only specific counterfeit batches have been identified. Most vaccines supplied through authorized channels are genuine.
Q2: What should I do if I suspect I received a fake vaccine?
Immediately consult a healthcare provider and provide your vaccination records, specifically the batch number, for verification.
